VIKING GLOBAL INVESTORS LP 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:21 am Purchase |
2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
VIKING GLOBAL INVESTORS LP | 6,599,062 9.990% |
436,700 (+7.09%) |
Filing |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
VIKING GLOBAL INVESTORS LP | 6,162,362 9.990% |
177,628 (+2.97%) |
Filing |
| 2022-10-07 5:29 pm Purchase |
2022-09-27 | 13G | Trevi Therapeutics, Inc. TRVI |
VIKING GLOBAL INVESTORS LP | 5,984,734 9.990% |
5,984,734 (New Position) |
Filing |